Multiple Myeloma

How Is MGUS Monitored?

https://vimeo.com/779453510 Myeloma expert Dr. Irene Ghobrial discusses how patients with monoclonal gammopathy of undetermined significance (MGUS) are monitored over time and shares an update on research being conducted to learn…

What Should Patients Know About Myeloma Testing?

https://vimeo.com/779453701 Testing following a myeloma diagnosis, or relapse, can impact care and treatment decisions. Drs. Betsy O’Donnell and Omar Nadeem provide an overview of essential myeloma testing, how the test…

Understanding MGUS & Smoldering Myeloma: What’s the Difference?

https://vimeo.com/779453854 Myeloma expert Dr. Irene Ghobrial explains the difference between the precursor conditions, MGUS (monocloncal gammopathy of undetermined significance) and smoldering myeloma, including how these conditions are detected. Dr. Irene…

Understanding Relapse in Myeloma

https://vimeo.com/777150292 What are indicators that a myeloma patient has relapsed? Dr. Mark Schroeder explains how relapsed and refractory myeloma are monitored and treated.  Dr. Mark Schroeder is a hematologist at…

Understanding Myeloma Treatment Types

https://vimeo.com/777150406 What are the types of treatment available for myeloma? Myeloma expert Dr. Mark Schroeder reviews the myeloma treatment classes, including proteasome inhibitors, immunomodulatory drugs (iMids), and immunotherapy. Dr. Schroeder…

What Are the Phases of Myeloma Treatment?

https://vimeo.com/777150583 Myeloma specialist Dr. Mark Schroeder explains the phases of myeloma treatment, defining induction, consolidation, and maintenance therapy for patients with myeloma. Dr. Mark Schroeder is a hematologist at Siteman…

Understanding MGUS, Smoldering and Multiple Myeloma

https://vimeo.com/777150726 What is the difference between smoldering myeloma and monoclonal gammopathy of undetermined significance (MGUS)? Dr. Mark Schroeder defines these diagnoses and discusses how asymptomatic myeloma is monitored. Dr. Mark…

Share On:

Facebook
Twitter
LinkedIn